Cite
HARVARD Citation
Dipasquale, V. et al. (2022). Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease. European journal of gastroenterology & hepatology. 34 (10), pp. 1007-1014. [Online].